Mobile

Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

Mise à jour : Il y a 4 ans
Référence : NCT00904371

Femme et Homme

  • | Pays :
  • Slovenia
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The study is designed to evaluate the effect of treatment with Micardis/MicardisPlus on blood pressure and its ability to reduce different indicated cardiovascular risks. Further on, the study will evaluate the current antihypertensive treatment pattern in the daily practice among the patient population at increased cardiovascular risk.

Critère d'inclusion

  • Hypertension ,Cardiovascular Diseases

Liens